Providing information for patients and professionals on research and clinical care in genetic types of diabetes.

Diabetes Drug Response


The Diabetes Drug Response website is managed by the NIHR Exeter Clinical Research Facility at the University of Exeter Medical School and Royal Devon and Exeter Hospital and is coming to the following addresses soon:

Current Research Studies: 


Randomised Double-Blind Crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as third line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on dual therapy with metformin and a sulphonylurea